Related references
Note: Only part of the references are listed.Diagnosis and management of pregnancies complicated by haemolysis, elevated liver enzymes and low platelets syndrome in the tertiary setting
Lulusha Jayawardena et al.
INTERNAL MEDICINE JOURNAL (2020)
High Fetal Fraction on First Trimester Cell-Free DNA Aneuploidy Screening and Adverse Pregnancy Outcomes
Lydia L. Shook et al.
AMERICAN JOURNAL OF PERINATOLOGY (2020)
The competing risk approach for prediction of preeclampsia
David Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)
Increased Cell-Free Fetal DNA Fraction in the First Trimester: A Sign of Abnormally Invasive Placenta?
Dagmar Wertaschnigg et al.
ULTRASCHALL IN DER MEDIZIN (2020)
Association of Fetal Fraction of Cell-Free DNA and Hypertensive Disorders of Pregnancy
Whitney R. Bender et al.
AMERICAN JOURNAL OF PERINATOLOGY (2019)
Human placental lactogen mRNA in maternal plasma play a role in prenatal diagnosis of abnormally invasive placenta: yes or no?
Jing Li et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy
Kristin D. Gerson et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2019)
Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology
Zain Awamleh et al.
BMC MEDICAL GENOMICS (2019)
Early second-trimester plasma cell free DNA levels with subsequent risk of pregnancy complications
Xiaosong Yuan et al.
CLINICAL BIOCHEMISTRY (2019)
The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs
Ilona Hromadnikova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
First Trimester Circulating MicroRNA Biomarkers Predictive of Subsequent Preterm Delivery and Cervical Shortening
Joanna Cook et al.
SCIENTIFIC REPORTS (2019)
Early diagnosis of gestational diabetes mellitus using circulating microRNAs
Liron Yoffe et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Association between fetal fraction at the second trimester and subsequent spontaneous preterm birth
Fang-fang Guo et al.
PRENATAL DIAGNOSIS (2019)
Effect of cell-free fetal DNA on spontaneous preterm labor
Rogaye Darghahi et al.
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2019)
Circulating Exosomal miRNA Profile During Term and Preterm Birth Pregnancies: A Longitudinal Study
Ramkumar Menon et al.
ENDOCRINOLOGY (2019)
Circular RNA expression profiles in placental villi from women with gestational diabetes mellitus
Linping Yan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy
Nobuhiro Suzumori et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)
Decreased Expression of Circulating miR-20a-5p in South African Women with Gestational Diabetes Mellitus
Carmen Pheiffer et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Central nervous system development-related microRNAs levels increase in the serum of gestational diabetic women during the first trimester of pregnancy
M. Lamadrid-Romero et al.
NEUROSCIENCE RESEARCH (2018)
Low-Dose Aspirin Use During Pregnancy
T. Flint Porter et al.
OBSTETRICS AND GYNECOLOGY (2018)
Micro RNA clusters in maternal plasma are associated with preterm birth and infant outcomes
Joel C. Wommack et al.
PLOS ONE (2018)
Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation
Tal Rafaeli-Yehudai et al.
PLOS ONE (2018)
Noninvasive blood tests for fetal development predict gestational age and preterm delivery
Thuy T. M. Ngo et al.
SCIENCE (2018)
Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia
D. L. Rolnik et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Molecular Biomarkers for Gestational Diabetes Mellitus
Stephanie Dias et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction
Danila Morano et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Cell-free fetal DNA and spontaneous preterm birth
Sara R. van Boeckel et al.
REPRODUCTION (2018)
Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study
N. Chan et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis
Elena Contro et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Morbidly adherent placenta: the need for standardization
A. Bhide et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2017)
First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR
Ilona Hromadnikova et al.
PLOS ONE (2017)
Circulating cell-free DNA concentration and DNase I activity of peripheral blood plasma change in case of pregnancy with intrauterine growth restriction compared to normal pregnancy
Elizaveta Ershova et al.
BIOMEDICAL REPORTS (2017)
Circulating early-and mid-pregnancy microRNAs and risk of gestational diabetes
Pandora L. Wander et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Small Molecule, Big Prospects: MicroRNA in Pregnancy and Its Complications
Meng Cai et al.
JOURNAL OF PREGNANCY (2017)
Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome
Rocio Munoz-Hernandez et al.
AMERICAN JOURNAL OF HYPERTENSION (2017)
Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation
Clare L. Whitehead et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Elevated Levels of Total Cell-Free DNA in Maternal Serum Samples Arise from the Generation of Neutrophil Extracellular Traps
Chanchal Sur Chowdhury et al.
FETAL DIAGNOSIS AND THERAPY (2016)
Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study
Radwa Marawan AbdelHalim et al.
MOLECULAR DIAGNOSIS & THERAPY (2016)
Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing
Iris Krishna et al.
PRENATAL DIAGNOSIS (2016)
Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomes
Florentine F. Thurik et al.
PRENATAL DIAGNOSIS (2016)
Consensus definition of fetal growth restriction: a Delphi procedure
S. J. Gordijn et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis
Pietro Amedeo Modesti et al.
PLOS ONE (2016)
Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line
Istvan Furi et al.
PLOS ONE (2015)
Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery
M. S. Quezada et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
STING: infection, inflammation and cancer
Glen N. Barber
NATURE REVIEWS IMMUNOLOGY (2015)
Quantification of circulating fetal DNA as a tool for potential monitoring of pregnant patients with antiphospholipid antibodies
Marie Korabecna et al.
AUTOIMMUNITY (2014)
Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments
Carson Ka-Lok Lo et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Circulating mRNA for the PLAC1 Gene as a Second Trimester Marker (14-18 Weeks' Gestation) in the Screening for Late Preeclampsia
Margherita Zanello et al.
FETAL DIAGNOSIS AND THERAPY (2014)
Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete
J. Zhou et al.
PLACENTA (2014)
Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy
Ana Luque et al.
SCIENTIFIC REPORTS (2014)
The Role of RNAs and microRNAs in Non-Invasive Prenatal Diagnosis
Antonio Farina
JOURNAL OF CLINICAL MEDICINE (2014)
Elevated Plasma Levels of Hypermethylated RASSF1A Gene Sequences in Pregnant Women with Intrahepatic Cholestasis
Ping Yi et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases
Zhen Zhao et al.
CLINICAL BIOCHEMISTRY (2013)
Global and regional estimates of preeclampsia and eclampsia: a systematic review
Edgardo Abalos et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
Cell-free fetal DNA and adverse outcome in low risk pregnancies
Werner Stein et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
Maternal Plasma Cell-Free Fetal and Maternal DNA at 11-13 Weeks' Gestation: Relation to Fetal and Maternal Characteristics and Pregnancy Outcomes
L. C. Y. Poon et al.
FETAL DIAGNOSIS AND THERAPY (2013)
Placental Specific mRNA in the Maternal Circulation Are Globally Dysregulated in Pregnancies Complicated by Fetal Growth Restriction
Clare L. Whitehead et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Quantitative analysis of fetal DNA in maternal plasma in gestational diabetes mellitus, iron deficiency anemia and gestational hypertension pregnancies
Mansour Zamanpoor et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2013)
Cell-Free Fetal DNA and Cell-Free Total DNA Levels in Spontaneous Abortion with Fetal Chromosomal Aneuploidy
Ji Hyae Lim et al.
PLOS ONE (2013)
Circulating mRNA for epidermal growth factor-like domain 7 (EGFL7) in maternal blood and early intrauterine growth restriction. A preliminary analysis
Margherita Zanello et al.
PRENATAL DIAGNOSIS (2013)
Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study
Amber Samuel et al.
PRENATAL DIAGNOSIS (2013)
Maternal Plasma miRNAs Expression in Preeclamptic Pregnancies
Hailing Li et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Molecular genetics of preeclampsia and HELLP syndrome - A review
Jiska Jebbink et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies
Liang Wu et al.
REPRODUCTION (2012)
Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women
Qi Yang et al.
CLINICA CHIMICA ACTA (2011)
Serum microRNA expression in pregnancies with preeclampsia
T. Gunel et al.
GENETICS AND MOLECULAR RESEARCH (2011)
Measurement of mRNA Transcripts of Very High Placental Expression in Maternal Blood as Biomarkers of Preeclampsia
Premila Paiva et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Early Second-Trimester Serum MiRNA Profiling Predicts Gestational Diabetes Mellitus
Chun Zhao et al.
PLOS ONE (2011)
Free fetal DNA levels in patients at risk of preterm labour
S. Illanes et al.
PRENATAL DIAGNOSIS (2011)
Higher circulating mRNA levels of placental specific genes in a patient with placenta accreta
Giuliana Simonazzi et al.
PRENATAL DIAGNOSIS (2011)
Expression Profile of MicroRNAs and mRNAs in Human Placentas From Pregnancies Complicated by Preeclampsia and Preterm Labor
Kathleen Mayor-Lynn et al.
REPRODUCTIVE SCIENCES (2011)
Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation
A. Sekizawa et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2010)
Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy
Silvia Galbiati et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Quantification of Extracellular DNA Using Hypermethylated RASSF1A, SRY, and GLO Sequences-Evaluation of Diagnostic Possibilities for Predicting Placental Insufficiency
Ilona Hromadnikova et al.
DNA AND CELL BIOLOGY (2010)
Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta
Manal M. El Behery et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2010)
The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction
J. -F. Mouillet et al.
PLACENTA (2010)
Quantity of total cell free and cell free fetal DNA in pregnancies with no complications and with preeclampsia
Levente Lázár et al.
ORVOSI HETILAP (2010)
Human Villous Trophoblasts Express and Secrete Placenta-Specific MicroRNAs into Maternal Circulation via Exosomes
Shan-Shun Luo et al.
BIOLOGY OF REPRODUCTION (2009)
Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator-Preliminary report
Engel Karina et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2009)
Total and Fetal Cell-Free DNA Analysis in Maternal Blood as Markers of Placental Insufficiency in Intrauterine Growth Restriction
M. Al Nakib et al.
FETAL DIAGNOSIS AND THERAPY (2009)
The correlation between clinical characteristics of preeclampsia and the concentration of fetal DNA in maternal circulation
Karina Engel et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2008)
Preterm birth 1 - Epidemiology and causes of preterm birth
Robert L. Goldenberg et al.
LANCET (2008)
Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy
Kiyonori Miura et al.
PRENATAL DIAGNOSIS (2008)
Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia
Antonio Farina et al.
PRENATAL DIAGNOSIS (2008)
Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia
A. Crowley et al.
PRENATAL DIAGNOSIS (2007)
Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies
Maddalena Smid et al.
PRENATAL DIAGNOSIS (2006)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA
T Wataganara et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Fetal cells and cell free fetal nucleic acids in maternal blood: New tools to study abnormal placentation?
S Hahn et al.
PLACENTA (2005)
High levels of fetal cell-free DNA in maternal serum: A risk factor for spontaneous preterm delivery
A Farina et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Placental mRNA in maternal plasma and its clinical application to the evaluation of placental status in a pregnant woman with placenta previa-percreta
H Masuzaki et al.
CLINICAL CHEMISTRY (2005)
Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsia
AM Cotter et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2005)
Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood
A Farina et al.
PRENATAL DIAGNOSIS (2004)
Circulating corticotropin-releasing hormone mRNA in maternal plasma: Relationship with gestational age and severity of preeclampsia
A Farina et al.
CLINICAL CHEMISTRY (2004)
β-globin DNA in maternal plasma as a molecular marker of pre-eclampsia
A Sekizawa et al.
PRENATAL DIAGNOSIS (2004)
Total cell-free DNA (β-globin gene) distribution in maternal plasma at the second trimester:: a new prospective for preeclampsia screening
A Farina et al.
PRENATAL DIAGNOSIS (2004)
Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling
NBY Tsui et al.
JOURNAL OF MEDICAL GENETICS (2004)
Anti-phospholipid and anti-DNA antibodies are not associated with the elevated release of circulatory fetal DNA in pregnancies affected by preeclampsia
S Hristoskova et al.
HYPERTENSION IN PREGNANCY (2004)
Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma
Y Sugito et al.
CLINICAL CHEMISTRY (2003)
The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia
EKO Ng et al.
CLINICAL CHEMISTRY (2003)
Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction - a pilot study
E Caramelli et al.
PRENATAL DIAGNOSIS (2003)
mRNA of placental origin is readily detectable in maternal plasma
EKO Ng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18
T Wataganara et al.
HUMAN GENETICS (2003)
Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction
A Sekizawa et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy
A Farina et al.
CLINICAL CHEMISTRY (2003)
Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia
XY Zhong et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Share Paper
